EUVIMEDEUVIMED entdecken
Open Access

Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome

Xue Li, Ruijun Deng, Jie Li, Hui Li, Zhe Xu, Lei Zhang, Linyin Feng, Chunying Shu, Mingming Zhen, Chunru Wang

Theranostics · 2023

DOI: 10.7150/thno.85711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Xue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for E…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fullerenes, Parkinson Disease, Neuroinflammatory Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeFullerenesParkinson DiseaseNeuroinflammatory DiseasesAnimalsMiceMaleDisease Models, AnimalMice, Inbred C57BLAdministration, Oral1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineRNA, Ribosomal, 16S

Stichwörter der Autor:innen

Gut microbiotaNeurodegenerationNeuroinflammationOral fullereneParkinson's disease

Substanzen

Fullerenes1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinefullerene C60RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Acade…
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Beijing Fullcan Biotechnology Co., Ltd., Beijing, 100085, China.
  • Chifeng Fullcan Biotechnology Co., Ltd., Inner Mongolia, 024099, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

Zitieren

APA

Li, X., Deng, R., Li, J., Li, H., Xu, Z., Zhang, L., Feng, L., Shu, C., Zhen, M., & Wang, C. (2023). Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome. Theranostics. https://doi.org/10.7150/thno.85711

Vancouver

Li X, Deng R, Li J, Li H, Xu Z, Zhang L, et al. Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome. Theranostics. 2023. doi:10.7150/thno.85711

BibTeX
@article{Li2023,
  author = {Li, Xue and Deng, Ruijun and Li, Jie and Li, Hui and Xu, Zhe and Zhang, Lei and Feng, Linyin and Shu, Chunying and Zhen, Mingming and Wang, Chunru},
  title = {Oral [60]fullerene reduces neuroinflammation to alleviate Parkinson's disease via regulating gut microbiome},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.85711}
}
Kostenlos starten →